Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium | Zendy

Silke Gillessen | Zendy; Nicolas Sauvé | Zendy; Laurence Collette | Zendy; Gedske Daugaard | Zendy; Ronald de Wit | Zendy; Costantine Albany | Zendy; А. А. Tryakin | Zendy; Karim Fizazi | Zendy; Olof Ståhl | Zendy; Jourik A. Gietema | Zendy; Ugo De Giorgi | Zendy; Fay H. Cafferty | Zendy; Aaron R. Hansen | Zendy; Torgrim Tandstad | Zendy; Robert Huddart | Zendy; Andrea Necchi | Zendy; Christopher J. Sweeney | Zendy; Xavier García del Muro | Zendy; Daniel Yick Chin Heng | Zendy; Anja Lorch | Zendy; Michal Chovanec | Zendy; Eric Winquist | Zendy; Peter Grimison | Zendy; Darren R. Feldman | Zendy; Angelika Terbuch | Zendy; Marcus Hentrich | Zendy; Carsten Bokemeyer | Zendy; Helene F. S. Negaard | Zendy; Christian D. Fankhauser | Zendy; Jonathan Shamash | Zendy; David J. Vaughn | Zendy; Cora N. Sternberg | Zendy; Axel Heidenreich | Zendy; J. Beyer | Zendy

Open Access

Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium

Author(s) -

Silke Gillessen,

Nicolas Sauvé,

Laurence Collette,

Gedske Daugaard,

Ronald de Wit,

Costantine Albany,

А. А. Tryakin,

Karim Fizazi,

Olof Ståhl,

Jourik A. Gietema,

Ugo De Giorgi,

Fay H. Cafferty,

Aaron R. Hansen,

Torgrim Tandstad,

Robert Huddart,

Andrea Necchi,

Christopher J. Sweeney,

Xavier García del Muro,

Daniel Yick Chin Heng,

Anja Lorch,

Michal Chovanec,

Eric Winquist,

Peter Grimison,

Darren R. Feldman,

Angelika Terbuch,

Marcus Hentrich,

Carsten Bokemeyer,

Helene F. S. Negaard,

Christian D. Fankhauser,

Jonathan Shamash,

David J. Vaughn,

Cora N. Sternberg,

Axel Heidenreich,

J. Beyer

Publication year - 2021

Publication title -

journal of clinical oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 10.482

H-Index - 548

eISSN - 1527-7755

pISSN - 0732-183X

DOI - 10.1200/jco.20.03296

Subject(s) - germ cell tumors , etoposide , medicine , oncology , chemotherapy , progression free survival , cisplatin , clinical trial

The classification of the International Germ Cell Cancer Collaborative Group (IGCCCG) plays a pivotal role in the management of metastatic germ cell tumors but relies on data of patients treated between 1975 and 1990.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Address

About

Learn

Download the Zendy App

Discover

Explore